Patients Dispensed Medications with Actionable Pharmacogenomic Biomarkers: Rates and Characteristics https://t.co/adQGzxLkXa
Check this article which goal was to assess the potential of knowing patients' genomic characteristics into prescribing practices by @nature https://t.co/6pwM7uVyG9 @PGx_FFUL #expectuseveryday #everydayisagenomicday
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…
Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? https://t.co/V6yDFEpJ63 #pharmacogenomics #Genetics #Genomics https://t.co/ydFkQfCjUD
RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…
RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…
RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…
RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…
RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
Bravo @smanzi2 ... fantastic work.
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…
Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescribed a second such medication, increasing the risk of toxicity. Despite @US_FDA recommendations, these genomic indicators are ra
RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…
Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on their genomics is "substantial." But many barriers remain: https://t.co/3GsU4G6siO
Measuring the gap - how often are medications prescribed where gene-based guidance might be available? Often - and note pharmacogenomic guidance will continue to grow, so the gap will widen if we don’t act. From team led by @dianboliu, senior @mandl
RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…
18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medication. Not measuring and acting on pharmacogenomics increases risk of toxicity and adverse events, particularly when the metab
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…
RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…
Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical informatics you can still apply to our Master’s program until February 5th: https://t.co/P4c96Lb4JW
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…
Establishing a need for genomically-informed medicine.
Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications. Pharmacogenomic-guided prescribing is low hanging fruit for improving medication safety. @GIMJournal @smanzi2 @DianboLi